Disclaimer: We may earn a commission if you make any purchase by clicking our links. Please see our detailed guide here.

Follow us on:

Google News
Whatsapp

Bharat Biotech Supplying Covid-19 Vaccine Covaxin to 18 States

IANS
IANS
Meet the voice behind Indo-Asian News Service (IANS), a storyteller navigating the currents of global events with precision and depth. Crafting narratives that bridge cultures, IANS brings you the pulse of the world in every word

Join the Opinion Leaders Network

Join the Techgenyz Opinion Leaders Network today and become part of a vibrant community of change-makers. Together, we can create a brighter future by shaping opinions, driving conversations, and transforming ideas into reality.

Bharat Biotech has been directly supplying its Covid-19 vaccine Covaxin to 18 states since May 1. The company said on Tuesday.

“Unflinching in our efforts, we will continue the steady supply of our Covaxin vaccine,” the Hyderabad-based vaccine maker tweeted.

The states are Andhra Pradesh, Assam, Bihar, Chhattisgarh, Delhi, Gujarat, Haryana, Jammu & Kashmir, Jharkhand, Karnataka, Madhya Pradesh, Maharashtra, Odisha, Tamil Nadu, Tripura, Telangana, Uttar Pradesh, and West Bengal.

The company, however, has not come out with details of the supplies like the number of doses supplied to the states. The company earlier said it started the supplies based on the allocations received by the Government of India.

“Requests have been received from other states, & will be processed for distribution based on the availability of stocks 24×7.” Bharat Biotech co-founder and Joint Managing Director Suchitra Ella had tweeted earlier.

Bharat Biotech had, on April 24, announced pricing for Covaxin. It fixed the price of Covaxin at Rs.600 per dose for state governments. However, it later slashed the price to Rs.400. This came after the Serum Institute of India (SII) cut the price of Covishield to Rs.300 from Rs.400 earlier.

The two vaccine makers slashed the prices. After the central government reportedly made a request to them amid the row over different pricing for the central and state governments.

Bharat Biotech fixed the price for private hospitals at Rs.1,200 per dose. This is twice the cost fixed for Covishield.

For exports, Bharat Biotech has priced India’s first indigenous Covid vaccine at $15-$20 (Rs 1,125-1,500).

Ever since the launch of the Covid vaccination program in India, Bharat Biotech and SII have been supplying their vaccines to the Centre at Rs.150 per dose.

While Bharat Biotech is likely to continue the supplies to the Centre at the same price, SII is seeking to revise this to Rs.400.

Both Bharat Biotech and SII have announced that they are reserving 50 percent of their production capacities for supplies to the central government.

Join 10,000+ Fellow Readers

Get Techgenyz’s roundup delivered to your inbox curated with the most important for you that keeps you updated about the future tech, mobile, space, gaming, business and more.

Recomended

Partner With Us

Digital advertising offers a way for your business to reach out and make much-needed connections with your audience in a meaningful way. Advertising on Techgenyz will help you build brand awareness, increase website traffic, generate qualified leads, and grow your business.

Power Your Business

Solutions you need to super charge your business and drive growth

More from this topic